Table 3.
Treatment Data and COVID-19 status of Breast Cancer Patients (N = 292).
| Patient characteristics | Details | N (%) |
|---|---|---|
| Pre-operative COVID-19 test Result (n = 206) | Positive | 10 (4.9) |
| Negative | 196 (95.1) | |
| Surgical Procedure (n = 206) | Modified Radical Mastectomy | 94 (45.6) |
| Simple Mastectomy + Sentinel node biopsy | 25 (12.1) | |
| Oncoplastic Conservative Surgery + Sentinel node biopsy | 66 (32.1) | |
| WLE and Axillary Sampling | 9 (4.4) | |
| Others (Reconstruction, Axillary Clearance) | 12 (5.8) | |
| Systemic Treatment (n = 86) | Neo adjuvant Chemotherapy | 74 (86.1) |
| Systemic Chemotherapy | 10 (11.6) | |
| Hormonal Treatment | 2 (2.3) | |
| COVID 19 status in patients on Neoadjuvant/Systemic Chemotherapy. (n = 86) | Positive | 4 (4.6) |
| Negative | 82 (95.4) |